iBio, Inc. Files 8-K Report
Ticker: IBIO · Form: 8-K · Filed: Apr 7, 2025 · CIK: 1420720
| Field | Detail |
|---|---|
| Company | Ibio, Inc. (IBIO) |
| Form Type | 8-K |
| Filed Date | Apr 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, sec-filing, disclosure
TL;DR
iBio filed a routine 8-K, no major news.
AI Summary
On April 7, 2025, iBio, Inc. filed an 8-K report detailing a Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. The filing does not contain specific financial figures or new material events beyond the standard reporting requirements.
Why It Matters
This 8-K filing serves as a standard disclosure for iBio, Inc., providing updates on financial statements and other events as required by the SEC.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report with no new material information that would significantly impact the company's risk profile.
Key Players & Entities
- iBio, Inc. (company) — Registrant
- April 7, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 001-35023 (other) — Commission File Number
- 26-2797813 (other) — IRS Employer Identification No.
- 11750 Sorrento Valley Road Suite 200 San Diego, California 92121 (address) — Principal Executive Offices
- ( 979 ) 446-0027 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing by iBio, Inc.?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure, Other Events, and to include Financial Statements and Exhibits as of April 7, 2025.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported in this filing is April 7, 2025.
In which state was iBio, Inc. incorporated?
iBio, Inc. was incorporated in Delaware.
What is the Commission File Number for iBio, Inc.?
The Commission File Number for iBio, Inc. is 001-35023.
What is the address of iBio, Inc.'s principal executive offices?
The address of iBio, Inc.'s principal executive offices is 11750 Sorrento Valley Road Suite 200 San Diego, California 92121.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 7, 2025 regarding iBio, Inc. (IBIO).